- Home
- BOF vs NRXS Comparison
BOF vs NRXS Comparison
Compare BOF & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOF
- NRXS
- Stock Information
- Founded
- BOF 2017
- NRXS 2011
- Country
- BOF United States
- NRXS United States
- Employees
- BOF N/A
- NRXS N/A
- Industry
- BOF Packaged Foods
- NRXS
- Sector
- BOF Consumer Staples
- NRXS
- Exchange
- BOF Nasdaq
- NRXS Nasdaq
- Market Cap
- BOF 15.1M
- NRXS 17.3M
- IPO Year
- BOF 2023
- NRXS 2023
- Fundamental
- Price
- BOF $1.87
- NRXS $2.97
- Analyst Decision
- BOF
- NRXS
- Analyst Count
- BOF 0
- NRXS 0
- Target Price
- BOF N/A
- NRXS N/A
- AVG Volume (30 Days)
- BOF 176.5K
- NRXS 30.7K
- Earning Date
- BOF 11-14-2024
- NRXS 11-12-2024
- Dividend Yield
- BOF N/A
- NRXS N/A
- EPS Growth
- BOF N/A
- NRXS N/A
- EPS
- BOF N/A
- NRXS N/A
- Revenue
- BOF $6,489,951.00
- NRXS $2,456,219.00
- Revenue This Year
- BOF N/A
- NRXS $383.16
- Revenue Next Year
- BOF N/A
- NRXS N/A
- P/E Ratio
- BOF N/A
- NRXS N/A
- Revenue Growth
- BOF 372.36
- NRXS N/A
- 52 Week Low
- BOF $0.61
- NRXS $2.00
- 52 Week High
- BOF $4.11
- NRXS $3.89
- Technical
- Relative Strength Index (RSI)
- BOF 51.97
- NRXS 71.68
- Support Level
- BOF $1.74
- NRXS $2.48
- Resistance Level
- BOF $1.90
- NRXS $2.83
- Average True Range (ATR)
- BOF 0.16
- NRXS 0.27
- MACD
- BOF -0.00
- NRXS 0.08
- Stochastic Oscillator
- BOF 48.25
- NRXS 100.00
About BOF BranchOut Food Inc.
Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are primarily located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).